M42 Announces Strategic Investment and Partnership with Leading Biotech Juvenescence
M42 announces a strategic investment and partnership with Juvenescence, a leading biotech company focused on extending human healthspan. This collaboration aims to develop cutting-edge therapies and advance research in longevity and age-related diseases.
Relation Therapeutics announces two strategic collaborations with GSK to the tune of $300m
Congratulations to the Relation team for securing this landmark partnership deal with GSK to advance therapeutics for fibrotic diseases and osteoarthritis. We’re […]